Loading provider…
Loading provider…
Hematology (Internal Medicine) Physician in Madison, WI
NPI: 1114121092Primary Practice Location
UNIVERSITY OF WI HOSPITALS & CLINICS AUTHORITY
1675 Highland Ave, Madison, WI
Primary Employer
University of Wisconsin Medical Foundation, Inc
uwhealth.org
HQ Phone
Get M.D. Christopher's Phone NumberMobile
Get M.D. Christopher's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardWI State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 42 | 68 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 27 | 53 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 27 | 30 |
| 4 | 36415Insertion of needle into vein for collection of blood sample | 14 | 25 |
| 5 | 99238Hospital discharge day management, 30 minutes or less | 13 | 14 |
DNA copy number changes in tumors within the spectrum of cellular, atypical, and metastasizing fibrous histiocytoma.
Authors: Yann Charli Joseph, Andrea Saggini, Leona Doyle, Christopher Fletcher, Jingly Weier, Sonia Mirza, Swapna Vemula, Philip Leboit
Publication Date: 2013-12-23
The histologic spectrum of soft tissue spindle cell tumors with NTRK3 gene rearrangements.
Authors: Albert Suurmeijer, Brendan Dickson, David Swanson, Lei Zhang, Yun-shao Sung, Hsuan-ying Huang, Christopher Fletcher, Cristina Antonescu
Publication Date: 2019-04-16
Authors: Schaefer, Inga-Marie, Fletcher, Christopher Dm, Hornick, Jason L
Journal: Mod Pathol
Publication Date: 2015-11-20
Lead Sponsor: PrECOG, LLC.
Collaborators: Genentech, Inc.
Intervention / Treatment: DRUG: Induction Venetoclax, DRUG: Maintenance Venetoclax
Lead Sponsor: University of Wisconsin, Madison
Collaborators: Medical College of Wisconsin
Intervention / Treatment: DRUG: Doxorubicin, DRUG: Rituximab, BIOLOGICAL: Pegfilgrastim, DRUG: Cyclophosphamide, DRUG: Prednisone, DRUG: Vincristine
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Lenalidomide, BIOLOGICAL: Blinatumomab